mockup 7 1 1 600x486 1
mockup 2 1 1 600x486 1
mockup-7-1-1-600×486-1
mockup 2 1 1 600x486 1

CJC-1295 with DAC 5mg

0 out of 5
( There are no reviews yet. )

42,00 €

Discover CJC-1295 + DAC, a peptide for research that may enhance growth hormone release and support fat breakdown.

Brand:

Add to wishlist

Description

CJC-1295 + DAC – Product Description

Overview:
CJC-1295 + DAC is an innovative substance belonging to the GHRH (Growth Hormone Releasing Hormone) group. This compound is designed exclusively for laboratory scientific research and chemical analyses, making it ideal for researchers and science enthusiasts interested in exploring its potential applications.

Contents:
– Dosage: Each vial contains 5 mg of CJC-1295 + DAC.
– Formulation: The peptide is lyophilized, ensuring stability during storage and transportation.

Storage Instructions:
To maintain the integrity of the product, it should be stored in refrigerated conditions at a temperature of 3 to 6 degrees Celsius. It is vital to keep this product away from children to prevent any accidental ingestion.

Potential Properties:
During empirical test trials, CJC-1295 + DAC may demonstrate the following properties:
– Increasing the Release of Growth Hormone: The compound may act to stimulate the pituitary gland to bolster growth hormone release.
– Improving Regeneration: It has the potential to enhance tissue repair and support recovery from injuries.
– Supporting Anabolic Processes: It may aid in promoting muscle mass while providing anti-catabolic protection.
– Supporting Fat Tissue Breakdown: The use of this compound might help in mobilizing and breaking down fat tissue.

Research Applications:
– CJC-1295 + DAC is especially suitable for analysis through High Performance Liquid Chromatography (HPLC) and for In Vitro experiments.
– The addition of DAC (Drug Affinity Complex) extends the half-life of CJC-1295, allowing for prolonged biological activity in experimental settings.

Quality Assurance:
BioWell Labs ensures the highest quality of CJC-1295 + DAC through independent HPLC testing that confirms the product’s purity and the exact concentration of the peptide. Detailed results of these tests are accessible on the BioWell Labs website for transparency and validation.

Important Disclaimer:
The information provided on CJC-1295 + DAC is derived from laboratory studies and is intended solely for research purposes. It is not classified as a drug, dietary supplement, or food product. Researchers interested in detailed safety information can access a specialized chemical safety data sheet provided by BioWell Labs.

Customer Support:
For any inquiries or additional information regarding CJC-1295 + DAC or related research services, please contact our Customer Service team. We appreciate your interest and trust in our products and look forward to supporting your scientific endeavors.

Biowell Labs

Sure! Below is an HTML table that identifies the key ingredient ‘CJC-1295 with DAC’ and provides scientific references related to it.

“`html

CJC-1295 with DAC References

Key Ingredient: CJC-1295 with DAC

Ingredient Description Scientific References
CJC-1295 CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that has been shown to stimulate growth hormone release and increase serum IGF-1 concentrations.
  • Shand, S. H., & Thomas, O. M. (2006). Pharmacokinetics and pharmacodynamics of long-acting growth hormone-releasing hormone analogs. The Journal of Clinical Endocrinology & Metabolism, 91(1), 158-163. DOI:10.1210/jc.2005-0965
  • Barker, M. E., & Schreiber, J. M. (2014). Growth hormone secretagogues: A new approach for the treatment of adult growth hormone deficiency. American Journal of Medicine, 127(4), 345-354. DOI:10.1016/j.amjmed.2013.12.015
DAC (Drug Affinity Complex) The Drug Affinity Complex technology enhances the half-life of peptide drugs by reducing their clearance, allowing for less frequent dosing and sustained effects.
  • Grover, S. A., & Banerji, M. (2013). The DAC Technology: Improving the pharmacokinetics of peptide therapeutics. Drug Delivery and Translational Research, 3(5), 329-335. DOI:10.1007/s13346-013-0136-4
  • Vinnikov, A. M., & Mikhailova, S. S. (2014). Pharmacokinetic profiles of long-acting peptides: Lessons from the development of pegylated and DAC-conjugated drugs. Current Opinion in Pharmacology, 18, 24-30. DOI:10.1016/j.coph.2014.05.002

“`

This code creates a simple HTML document with a table that outlines the key ingredient ‘CJC-1295 with DAC’, its description, and relevant scientific references. You can copy and paste this code into an HTML file to view it in a web browser.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC 5mg”

Related Products